4131 Share Price Performance
NT$33.50
4.00 (13.56%)
Price NT$33.50
Share PriceNT$33.50
NeoCore Technology Co., Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
4131 Community Narratives
There are no narratives available yet.
Recent 4131 News & Updates
NeoCore Technology Co., Ltd. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.45
- Gross Margin
- 32.88%
- Net Profit Margin
- -11.74%
- Debt/Equity Ratio
- 28.8%
NeoCore Technology Co., Ltd. Competitors
Snowflake Analysis
About 4131
- Founded
- 1987
- Employees
- n/a
- CEO
- WebsiteView website
NeoCore Technology Co., Ltd. designs, manufactures, and sells biochips and rapid nucleic acid hybridization devices. The company’s products include food safety examination systems, human diagnosis arrays systems, agriculture examination systems, food examination arrays systems, and laboratory instruments, as well as DNA kits. It also offers laboratory planning, design, and other services. In addition, the company engages in the wholesale and retail of contact lenses. The company was formerly known as DR. Chip Biotechnology Incorporation and changed its name to NeoCore Technology Co., Ltd. in July 2023. NeoCore Technology Co., Ltd. was founded in 1987 and is headquartered in Tainan, Taiwan.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
Taiwanese Market Performance
- 7 Days: 3.8%
- 3 Months: 18.7%
- 1 Year: 17.6%
- Year to Date: 17.4%
Over the last 7 days, the market has risen 3.8%, driven by gains of 5.5% in the Information Technology sector. Meanwhile, the Healthcare sector has underperformed, shrinking 3.9% in that time. The market is up 18% over the last 12 months. Earnings are forecast to grow by 18% annually. Market details ›